Kathrin M. Bernt
Children's Hospital of Philadelphia(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Epigenetics and DNA Methylation, Protein Degradation and Inhibitors, CAR-T cell therapy research
Most-Cited Works
- → Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor(2011)930 cited
- → Chromatin-modifying enzymes as modulators of reprogramming(2012)632 cited
- → The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution(2020)574 cited
- → Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2(2020)413 cited
- → MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches(2017)403 cited
- → DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia(2015)249 cited
- → AF10 Regulates Progressive H3K79 Methylation and HOX Gene Expression in Diverse AML Subtypes(2014)181 cited
- → Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l(2013)172 cited
- → Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(2014)153 cited
- → A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells(2006)152 cited